Explore CRISPR technology explained, gene editing science, DNA modification, and genetic engineering ethics—discover how ...

In a Phase 1, first-in-human trial, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) was safe and reduced LDL cholesterol by nearly 50% and ...

Pioneering CRISPR trial shows single infusion permanently lowers bad cholesterol by 50% in patients who don't respond to medication.

In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...

We have written about the promise of gene therapy to correct genetic disease many times. An exciting development happened ...

A new CRISPR-based gene-editing therapy shows promise for treating severe high cholesterol by disabling the ANGPTL3 gene.

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

This is a preview. Log in through your library . Abstract CRISPR/Cas9 technology has immense power to reproduce plants with desired characters and revolutionizing the field of genome engineering by ...

University of California, Berkeley, researchers have made a major improvement in CRISPR-Cas9 technology that achieves an unprecedented success rate of 60 percent when replacing a short stretch of DNA ...